BioForce Pays for $2.48M in Services with 4.5M Restricted Shares
Summary
BioForce issued 4.5 million restricted shares valued at $2.48 million to pay for services, conserving its near-zero cash but diluting shareholders.
Key Events · Financing and Capital Events · BFNH
-
4.5M Restricted Shares Issued
On August 31, 2026, BioForce issued 4,516,909 restricted shares of common stock in a private placement under Section 4(2).
-
Services Valued at $2.48M
The shares were issued in consideration of services valued at $2,484,300, with no commissions or fees paid by the company.
-
Cash Conservation
The equity-for-services transaction preserves BioForce's minimal cash position, which stood at just $307 as of the last 10-Q.
-
Dilution Impact
The issuance adds approximately 4.5 million shares to the outstanding count, diluting existing shareholders.
Analysis · BFNH · Industrial Applications And Services
To cover $2,484,300 in services, BioForce issued 4,516,909 restricted shares—a non-cash move that avoids further draining its $307 cash balance but adds roughly 4.5 million shares to the float. With zero revenue and a going-concern warning, using equity as currency is a survival tactic rather than a sign of strength. The shares are restricted, so near-term selling pressure is limited, yet the issuance still dilutes existing holders.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 29.9% of the 1939 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BFNH was trading at $6.09 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $204.3M. The 52-week trading range was $0.16 to $6.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.